
Group Structure
View All
Industry
Other human health activities
Registered Address
30 clapham common north side, london, SW4 0RN
Pomanda estimates the enterprise value of ROYAL TRINITY HOSPICE at £12.1m based on a Turnover of £17.9m and 0.67x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ROYAL TRINITY HOSPICE at £0 based on an EBITDA of £-1.6m and a 5.11x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ROYAL TRINITY HOSPICE at £47.1m based on Net Assets of £21.1m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Royal Trinity Hospice is a live company located in london, SW4 0RN with a Companies House number of 02673845. It operates in the other human health activities sector, SIC Code 86900. Founded in December 1991, it's largest shareholder is unknown. Royal Trinity Hospice is a mature, mid sized company, Pomanda has estimated its turnover at £17.9m with low growth in recent years.
Pomanda's financial health check has awarded Royal Trinity Hospice a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
5 Weak
Size
annual sales of £17.9m, make it larger than the average company (£730.1k)
£17.9m - Royal Trinity Hospice
£730.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (7.2%)
3% - Royal Trinity Hospice
7.2% - Industry AVG
Production
with a gross margin of 38.5%, this company has a comparable cost of product (38.5%)
38.5% - Royal Trinity Hospice
38.5% - Industry AVG
Profitability
an operating margin of -13.7% make it less profitable than the average company (5.2%)
-13.7% - Royal Trinity Hospice
5.2% - Industry AVG
Employees
with 282 employees, this is above the industry average (18)
282 - Royal Trinity Hospice
18 - Industry AVG
Pay Structure
on an average salary of £51k, the company has a higher pay structure (£26.5k)
£51k - Royal Trinity Hospice
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £63.4k, this is more efficient (£45.8k)
£63.4k - Royal Trinity Hospice
£45.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Royal Trinity Hospice
- - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (18 days)
5 days - Royal Trinity Hospice
18 days - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (13 days)
0 days - Royal Trinity Hospice
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 65 weeks, this is less cash available to meet short term requirements (124 weeks)
65 weeks - Royal Trinity Hospice
124 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.6%, this is a lower level of debt than the average (22.6%)
5.6% - Royal Trinity Hospice
22.6% - Industry AVG
Royal Trinity Hospice's latest turnover from March 2024 is £17.9 million and the company has net assets of £21.1 million. According to their latest financial statements, Royal Trinity Hospice has 282 employees and maintains cash reserves of £1.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 17,889,884 | 15,640,826 | 16,379,644 | 16,450,403 | 15,275,222 | 15,375,105 | 11,878,193 | 12,427,649 | 12,672,970 | 11,061,241 | 10,802,632 | 10,320,154 | 10,036,301 | 9,473,192 | 8,773,149 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | -2,304,600 | -1,614,249 | 2,061,777 | 2,371,327 | -854,213 | 333,399 | -1,441,499 | -702,035 | 270,223 | -118,925 | 58,174 | 177,628 | 596,816 | 742,390 | 294,165 |
Tax | |||||||||||||||
Profit After Tax | -2,304,600 | -1,614,249 | 2,061,777 | 2,371,327 | -854,213 | 333,399 | -1,441,499 | -702,035 | 270,223 | -118,925 | 58,174 | 177,628 | 596,816 | 742,390 | 294,165 |
Dividends Paid | |||||||||||||||
Retained Profit | -2,304,600 | -1,614,249 | 2,061,777 | 2,371,327 | -854,213 | 333,399 | -1,441,499 | -702,035 | 270,223 | -118,925 | 58,174 | 177,628 | 596,816 | 742,390 | 294,165 |
Employee Costs | 14,369,187 | 12,541,244 | 10,085,194 | 9,763,622 | 11,141,051 | 10,550,418 | 9,462,352 | 9,347,038 | 8,896,708 | 8,186,271 | 7,623,589 | 7,169,693 | 6,691,272 | 5,920,950 | 5,888,096 |
Number Of Employees | 282 | 253 | 237 | 247 | 259 | 253 | 235 | 226 | 220 | 201 | 189 | 186 | 169 | 149 | 146 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 6,416,956 | 6,818,193 | 7,088,234 | 7,701,755 | 8,534,411 | 8,924,744 | 9,349,082 | 9,766,744 | 10,311,641 | 11,096,101 | 11,045,091 | 11,372,168 | 11,774,934 | 11,552,082 | 11,776,173 |
Intangible Assets | |||||||||||||||
Investments & Other | 11,684,440 | 11,037,588 | 10,271,946 | 10,250,646 | 10,076,027 | 10,374,226 | 10,729,671 | 10,708,060 | 10,333,213 | 3,436,197 | 3,145,544 | 2,958,759 | 2,249,985 | 1,821,821 | 1,749,429 |
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 18,101,396 | 17,855,781 | 17,360,180 | 17,952,401 | 18,610,438 | 19,298,970 | 20,078,753 | 20,474,804 | 20,644,854 | 14,532,298 | 14,190,635 | 14,330,927 | 14,024,919 | 13,373,903 | 13,525,602 |
Stock & work in progress | 19,422 | 13,863 | 13,026 | 32,151 | 42,956 | 39,619 | 53,314 | 50,651 | 19,714 | 95,572 | 75,301 | 83,417 | 50,954 | 61,845 | 64,566 |
Trade Debtors | |||||||||||||||
Group Debtors | 151 | 29,124 | |||||||||||||
Misc Debtors | 2,688,496 | 1,813,268 | 2,490,597 | 2,529,268 | 1,632,966 | 1,460,547 | 1,321,557 | 1,183,293 | 1,127,049 | 821,572 | 2,028,337 | 671,790 | 602,925 | 378,839 | 282,737 |
Cash | 1,559,543 | 4,293,350 | 5,731,785 | 4,558,116 | 933,676 | 1,213,106 | 172,321 | 1,159,158 | 324,827 | 3,384,946 | 2,199,784 | 2,934,480 | 2,863,970 | 1,074,516 | 735,540 |
misc current assets | 9,736 | 201,549 | 1,750,575 | 1,859,811 | 1,219,621 | ||||||||||
total current assets | 4,267,461 | 6,120,481 | 8,235,408 | 7,119,535 | 2,609,749 | 2,742,396 | 1,556,928 | 2,594,651 | 3,222,165 | 4,302,090 | 4,303,422 | 3,689,687 | 3,517,849 | 3,375,011 | 2,302,464 |
total assets | 22,368,857 | 23,976,262 | 25,595,588 | 25,071,936 | 21,220,187 | 22,041,366 | 21,635,681 | 23,069,455 | 23,867,019 | 18,834,388 | 18,494,057 | 18,020,614 | 17,542,768 | 16,748,914 | 15,828,066 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 155,420 | 234,701 | 113,184 | 70,966 | 120,383 | 95,849 | 106,906 | 162,280 | 271,095 | 297,835 | 246,973 | 294,317 | 309,513 | 227,317 | 122,684 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 1,091,576 | 884,065 | 771,210 | 2,404,343 | 1,005,088 | 765,436 | 626,626 | 589,239 | 935,745 | 1,314,150 | 1,064,865 | 766,645 | 744,596 | 670,224 | 644,489 |
total current liabilities | 1,246,996 | 1,118,766 | 884,394 | 2,475,309 | 1,125,471 | 861,285 | 733,532 | 751,519 | 1,206,840 | 1,611,985 | 1,311,838 | 1,060,962 | 1,054,109 | 897,541 | 767,173 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | 1,246,996 | 1,118,766 | 884,394 | 2,475,309 | 1,125,471 | 861,285 | 733,532 | 751,519 | 1,206,840 | 1,611,985 | 1,311,838 | 1,060,962 | 1,054,109 | 897,541 | 767,173 |
net assets | 21,121,861 | 22,857,496 | 24,711,194 | 22,596,627 | 20,094,716 | 21,180,081 | 20,902,149 | 22,317,936 | 22,660,179 | 17,222,403 | 17,182,219 | 16,959,652 | 16,488,659 | 15,851,373 | 15,060,893 |
total shareholders funds | 21,121,861 | 22,857,496 | 24,711,194 | 22,596,627 | 20,094,716 | 21,180,081 | 20,902,149 | 22,317,936 | 22,660,179 | 17,222,403 | 17,182,219 | 16,959,652 | 16,488,659 | 15,851,373 | 15,060,893 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 899,688 | 869,626 | 857,960 | 871,353 | 990,071 | 841,140 | 806,030 | 783,153 | 585,693 | 509,349 | 572,854 | 584,169 | 593,640 | 590,156 | 116,263 |
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | 5,559 | 837 | -19,125 | -10,805 | 3,337 | -13,695 | 2,663 | 30,937 | -75,858 | 20,271 | -8,116 | 32,463 | -10,891 | -2,721 | 64,566 |
Debtors | 875,228 | -677,329 | -38,671 | 896,151 | 143,446 | 168,114 | 138,264 | 56,244 | 305,477 | -1,206,765 | 1,356,547 | 68,865 | 224,086 | 96,102 | 282,737 |
Creditors | -79,281 | 121,517 | 42,218 | -49,417 | 24,534 | -11,057 | -55,374 | -108,815 | -26,740 | 50,862 | -47,344 | -15,196 | 82,196 | 104,633 | 122,684 |
Accruals and Deferred Income | 207,511 | 112,855 | -1,633,133 | 1,399,255 | 239,652 | 138,810 | 37,387 | -346,506 | -378,405 | 249,285 | 298,220 | 22,049 | 74,372 | 25,735 | 644,489 |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | 1,647,580 | -333,779 | 603,987 | -1,530,696 | -268,169 | -596,812 | -1,204,185 | -390,367 | -608,747 | ||||||
Change in Investments | 646,852 | 765,642 | 21,300 | 174,619 | -298,199 | -355,445 | 21,611 | 374,847 | 6,897,016 | 290,653 | 186,785 | 708,774 | 428,164 | 72,392 | 1,749,429 |
cash flow from investments | -646,852 | -765,642 | -21,300 | -174,619 | 298,199 | 2,003,025 | -355,390 | 229,140 | -8,427,712 | -290,653 | -454,954 | -1,305,586 | -1,632,349 | -462,759 | -2,358,176 |
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | 568,965 | -239,449 | 52,790 | 130,584 | -231,152 | -55,467 | 25,712 | 359,792 | 5,167,553 | 159,109 | 164,393 | 293,365 | 40,470 | 48,090 | 14,766,728 |
cash and cash equivalents | |||||||||||||||
cash | -2,733,807 | -1,438,435 | 1,173,669 | 3,624,440 | -279,430 | 1,040,785 | -986,837 | 834,331 | -3,060,119 | 1,185,162 | -734,696 | 70,510 | 1,789,454 | 338,976 | 735,540 |
overdraft | |||||||||||||||
change in cash | -2,733,807 | -1,438,435 | 1,173,669 | 3,624,440 | -279,430 | 1,040,785 | -986,837 | 834,331 | -3,060,119 | 1,185,162 | -734,696 | 70,510 | 1,789,454 | 338,976 | 735,540 |
Perform a competitor analysis for royal trinity hospice by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SW4 area or any other competitors across 12 key performance metrics.
ROYAL TRINITY HOSPICE group structure
Royal Trinity Hospice has 1 subsidiary company.
Ultimate parent company
ROYAL TRINITY HOSPICE
02673845
1 subsidiary
Royal Trinity Hospice currently has 15 directors. The longest serving directors include Mr Adrian Williams (Jun 2014) and Mr James Piper (Apr 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Adrian Williams | 59 years | Jun 2014 | - | Director | |
Mr James Piper | United Kingdom | 41 years | Apr 2018 | - | Director |
Ms Alison Petit | 55 years | Apr 2018 | - | Director | |
Mr Gerard Manley | 66 years | Jun 2018 | - | Director | |
Mr Stefan Laban | United Kingdom | 61 years | Feb 2021 | - | Director |
Ms Angela Dawe | 68 years | Feb 2021 | - | Director | |
Mr Stefan Laban | 61 years | Feb 2021 | - | Director | |
Mr David Carmalt | 48 years | Feb 2021 | - | Director | |
Mr Jonathan Kembery | 58 years | Feb 2021 | - | Director | |
Ms Angela Marcelle | 63 years | Feb 2021 | - | Director |
P&L
March 2024turnover
17.9m
+14%
operating profit
-2.5m
0%
gross margin
38.5%
+2.84%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
21.1m
-0.08%
total assets
22.4m
-0.07%
cash
1.6m
-0.64%
net assets
Total assets minus all liabilities
company number
02673845
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
December 1991
age
34
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
March 2024
previous names
trinity hospice (November 2015)
trinity hospice, clapham (September 2004)
accountant
-
auditor
SAFFERY LLP
address
30 clapham common north side, london, SW4 0RN
Bank
BARCLAYS BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to royal trinity hospice.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ROYAL TRINITY HOSPICE. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|